JNE Partners LLP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAU and the CUSIP is G6780C125. A total of 22 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
JNE Partners LLP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$14,640,000
-0.1%
1,500,0000.0%11.07%
+9.2%
Q4 2022$14,655,000
-0.8%
1,500,0000.0%10.14%
+18.6%
Q3 2022$14,775,000
+0.1%
1,500,0000.0%8.55%
-11.3%
Q2 2022$14,759,000
+0.7%
1,500,0000.0%9.64%
+38.9%
Q1 2022$14,655,000
-0.9%
1,500,0000.0%6.94%
-28.4%
Q4 2021$14,790,000
-0.4%
1,500,0000.0%9.69%
+15.8%
Q3 2021$14,851,000
-1.5%
1,500,0000.0%8.37%
-24.3%
Q2 2021$15,075,0001,500,00011.06%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q3 2021
NameSharesValueWeighting ↓
JNE Partners LLP 1,500,000$14,851,0008.37%
Kepos Capital LP 500,000$4,965,0000.34%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,950,0000.31%
Wealthspring Capital LLC 112,910$1,118,0000.27%
First Trust Capital Management L.P. 175,000$1,733,0000.26%
PERISCOPE CAPITAL INC. 600,000$5,958,0000.18%
Shaolin Capital Management LLC 523,570$5,184,0000.16%
Sage Mountain Advisors LLC 80,000$792,0000.11%
Context Capital Management, LLC 105,800$1,047,0000.11%
Magnetar Financial LLC 600,000$5,997,0000.06%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders